Physicochemical Properties
| Molecular Formula | C11H16N6O7S |
| Molecular Weight | 376.345740318298 |
| Exact Mass | 376.08 |
| CAS # | 2226227-75-2 |
| PubChem CID | 134501092 |
| Appearance | White to off-white solid powder |
| LogP | -2.6 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 5 |
| Heavy Atom Count | 25 |
| Complexity | 576 |
| Defined Atom Stereocenter Count | 4 |
| SMILES | O[C@@H]1[C@@H]([C@H](O[C@H]1N1N=C(C2=C(N=CN=C12)N)OC)COS(=O)(=O)N)O |
| InChi Key | SVHOPJCSYNTLAH-RPKMEZRRSA-N |
| InChi Code | InChI=1S/C11H16N6O7S/c1-22-10-5-8(12)14-3-15-9(5)17(16-10)11-7(19)6(18)4(24-11)2-23-25(13,20)21/h3-4,6-7,11,18-19H,2H2,1H3,(H2,12,14,15)(H2,13,20,21)/t4-,6-,7-,11-/m1/s1 |
| Chemical Name | [(2R,3S,4R,5R)-5-(4-amino-3-methoxypyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl sulfamate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Discovery and optimization of pyrazolopyrimidine sulfamates as ATG7 inhibitors. Bioorg Med Chem. 2020 Oct 1;28(19):115681. |
Solubility Data
| Solubility (In Vitro) |
DMSO : ~100 mg/mL (~265.71 mM) H2O : ~0.5 mg/mL (~1.33 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 25 mg/mL (66.43 mM) in Saline (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: 25 mg/mL (66.43 mM) in 20% HP-β-CD in Saline (add these co-solvents sequentially from left to right, and one by one), clear solution; Need ultrasonic and adjust pH to 4 with 1M HCl. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.6571 mL | 13.2855 mL | 26.5710 mL | |
| 5 mM | 0.5314 mL | 2.6571 mL | 5.3142 mL | |
| 10 mM | 0.2657 mL | 1.3286 mL | 2.6571 mL |